The underlying causes of persistent, unexplained eosinophilia were explored among patients of an inner-city allergy clinic.

Building on research showing greater risk for IHD among women with adult-onset asthma, researchers examined the link between IHD and asthma severity.

A study tested the effects of a COVID-19 Vaccine Allergy Program using skin prick testing and shared decision-making on vaccine-hesitant health care workers.

How well does berotralstat control hereditary angioedema in a real-world population over the course of a year?

Researchers analyzed patients with aspirin-exacerbated respiratory disease to determine the safety and efficacy of a one-day oral aspirin desensitization protocol.

Study authors explored the effect of albuterol/budesonide fixed combination therapy on asthma deterioration and severe asthma exacerbations compared with albuterol, budesonide, or placebo.

How does split dosing of COVID-19 vaccines compare with conventional dosing with respect to antibody responsiveness and safety?

In patients using as-needed short-acting beta2-agonists, how are exacerbations associated with asthma control, maintenance adherence, and disease severity?

A real-world study assessed how pediatric patients with moderate to severe asthma responded to the use dupilumab, mepolizumab, and omalizumab.

How rapid is the onset of effective action when using azelastine HCl 0.15% to relieve nasal symptoms of seasonal allergic rhinitis?

While mepolizumab has proven safe and effective for severe asthma, how has it performed in treating those with allergic vs non-allergic asthma?

Researchers assessed the link between smell loss in CRSwNP and other disease attributes, as well as the effect of dupilumab according to smell loss severity.

What are the most significant predictors of airflow limitation in children 5 to 18 years of age with severe asthma?

Which clinical screening markers predict aspirin-exacerbated respiratory disease in patients with chronic rhinosinusitis with nasal polyps?

How does having atopic dermatitis at 2 years of age affect the risk of developing allergic respiratory disease by 10 years of age?

The phase 3 EPITOPE trial assessed the safety and efficacy of epicutaneous immunotherapy for peanut allergy in children under 4 years old.

Researchers analyzed pooled safety data from 3 clinical trials of lebrikizumab for uncontrolled asthma to determine the drug’s safety profile.

A post hoc analysis of the PATHWAY and NAVIGATOR trials assessed efficacy of tezepelumab in Hispanic/Latino patients with severe, uncontrolled asthma.

Researchers evaluated asthma control in participants receiving maintenance and reliever digital system vs standard maintenance and reliever inhalers.

How do hereditary angioedema attack rates differ in patients treated with lanadelumab treatment every other week vs daily berotralstat?

Researchers compared asthma exacerbation and cotricosteroid prescription reduction patients with asthma treated with dupilumab vs omalizumab, benralizumab, or mepolizumab.

A phase 3 trial evaluated the effects of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis without nasal polyps.

Which is a better predictor of morbidity in patients with severe asthma, blood eosinophil count or the number of patient-reported asthma triggers?

A survey explored triggers for use of epinephrine injection devices and why patients with allergies and their caregivers often delay epinephrine administration.